FOXO Technologies Overview
- Status
-
Public
- Employees
-
192
- Stock Symbol
-
FOXO
- Investments
-
6
- Share Price
-
$0.10
- (As of Thursday Closing)
FOXO Technologies General Information
Description
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.
Contact Information
Website
www.foxotechnologies.comCorporate Office
- 477 South Rosemary Avenue
- Suite 224
- West Palm Beach, FL 33401
- United States
Corporate Office
- 477 South Rosemary Avenue
- Suite 224
- West Palm Beach, FL 33401
- United States
FOXO Technologies Stock Performance
As of 19-Nov-2026, FOXO Technologies’s stock price is $0.10. Its current market cap is $166K with 1.66M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.10 | $0.15 | $166K | 1.66M | 8.13K | $2.28K |
FOXO Technologies Financials Summary
As of 30-Sep-2026, FOXO Technologies has a trailing 12-month revenue of $21.3M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 20,711 | 10,352 | 41,125 | 5,688 |
| Revenue | 21,318 | 16,368 | 4,052 | 145 |
| EBITDA | 2,091 | (8,599) | (7,276) | (24,108) |
| Net Income | (2,626) | (12,430) | (12,406) | (26,451) |
| Total Assets | 43,603 | 44,578 | 41,708 | 726 |
| Total Debt | 21,209 | 10,966 | 14,255 | 4,993 |
FOXO Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
FOXO Technologies Comparisons
Industry
Financing
Details
FOXO Technologies Competitors (4)
One of FOXO Technologies’s 4 competitors is Pacific BioSciences of California, a Formerly VC-backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pacific BioSciences of California | Formerly VC-backed | Menlo Park, CA | ||||
| Lucid Diagnostics | Corporation | New York, NY | ||||
| Bestow | Venture Capital-Backed | Dallas, TX | ||||
| Ladder | Venture Capital-Backed | Palo Alto, CA |
FOXO Technologies Signals
FOXO Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
FOXO Technologies Acquisitions (6)
FOXO Technologies’s most recent deal was a Merger/Acquisition with Ludwig Enterprises. The deal was made on 29-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ludwig Enterprises | 29-Oct-2026 | Merger/Acquisition | Biotechnology | ||
| Vector Biosource | 22-Sep-2025 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Big South Fork Medical Center | 17-Sep-2024 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Myrtle Recovery Centers | 14-Jun-2024 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Delwinds Insurance Acquisition | 15-Sep-2022 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
FOXO Technologies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Facilities
Subindustry
Rank
Percentile
FOXO Technologies Exits (1)
FOXO Technologies’s most recent exit was on 20-Aug-2021 from FOXO Life. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| FOXO Life | 20-Aug-2021 | Completed |
|
FOXO Technologies Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Myrtle Recovery Centers | Oneida, TN | 2023 | |
| Vector Biosource | Stoughton, MA | 2023 | |
| Delwinds Insurance Acquisition | Houston, TX | 2020 | |
| Big South Fork Medical Center | Oneida, TN | 1955 |
FOXO Technologies FAQs
-
Where is FOXO Technologies headquartered?
FOXO Technologies is headquartered in West Palm Beach, FL.
-
What is the size of FOXO Technologies?
FOXO Technologies has 192 total employees.
-
What industry is FOXO Technologies in?
FOXO Technologies’s primary industry is Hospitals/Inpatient Services.
-
Is FOXO Technologies a private or public company?
FOXO Technologies is a Public company.
-
What is FOXO Technologies’s stock symbol?
The ticker symbol for FOXO Technologies is FOXO.
-
What is the current stock price of FOXO Technologies?
As of 19-Nov-2026 the stock price of FOXO Technologies is $0.10.
-
What is the current market cap of FOXO Technologies?
The current market capitalization of FOXO Technologies is $166K.
-
What is FOXO Technologies’s current revenue?
The trailing twelve month revenue for FOXO Technologies is $21.3M.
-
Who are FOXO Technologies’s competitors?
Pacific BioSciences of California, Lucid Diagnostics, Bestow, and Ladder are competitors of FOXO Technologies.
-
What is FOXO Technologies’s annual earnings per share (EPS)?
FOXO Technologies’s EPS for 12 months was $2.28K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process